期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

腹股沟斜疝并血小板无力症1例报告

下载PDF
导出
摘要 1临床资料1.1病例资料患者,男,31岁,因右侧腹股沟可复性肿物近2年于2014年2月10日入院。青年男性,病史长。既往：无手术史。自诉平时易发生轻微鼻衄,皮肤粘膜较易外伤淤青,原因不祥,家族无类似病例,父母无近亲结婚史。否认服用阿司匹林、氯雷他定等药物。症状体征无异常。查体：腹壁平坦,腹股沟区有肿物及偶有腹胀。患者站立及咳嗽时肿物自阴囊突出。
作者 姚浩琛 杜晓宏 王春丽 张平
机构地区 吉林大学白求恩第一医院肝胆胰外科一组
出处 《中国实验诊断学》 2016年第7期1187-1189,共3页 Chinese Journal of Laboratory Diagnosis
关键词 氯雷他定 腹股沟外环 右侧腹股沟 近亲结婚 症状体征 腹股沟区 皮肤粘膜 血小板功能 临床资料 皮肤黏膜淤点
分类号 R656.21 [医药卫生—外科学]
  • 相关文献

参考文献9

  • 1阶平,裘法祖.黄家驷外科学[M].6版.北京:人民卫生出版社,2005:1271.
  • 2Franchini M, Favaloro E J, Lippi G. Glanzmann thrombasthenia: an update[J]: Cliniea Chimica Acta, 2010,411 (1) : 1.
  • 3SEBASTIANOC,BROMBERG M, BREEN K et al. Glanzmann' s thrombasthenia: report of a case and review of the literature [J]. Int JClin Exp Pathol,2010,3:443.
  • 4NURDEN AT. Glanzmann thrombasthenia[J]. Orphanet JRare Dis, 2006,1 : 10. PMID: 16722529.
  • 5沈卫章,王鸿利.血小板无力症的临床诊断和发病机制的研究进展[J].诊断学理论与实践,2005,4(6):502-504. 被引量：5
  • 6Santoro C,Rago A, Biondo F, et al. Prevalence of alloimmuniza- tion anti-HLA and anti-integrin alphaIIbbeta3 in Glanzmann thromboasthenia patients[J]. H aemophilia, 2010,16 ( 5 ) : 805.
  • 7Tanaka KA, Taketorni T, Szlam F, et al. Improved clot formation by combined administration of activated faetor~ (NovoSeven) and fibrino- gen (Haemocomplettan P)[J].Anesth Analg,2008,106(3) :732.
  • 8Poon MC,D~Oiron R,von Depka M,et al. Prophylactic and thera- peutic recombinant factor ~ a administration to patients with Glanzmann's thrombasthenia: results of an international survey [J].J Thromb Haemost,2004,2(7) :1096.
  • 9Wiegering V, Winkler B, Langhammer F, et al. Allogeneie hema- topoietic stem cell transplantation in Glanzmann thrombasthenia complicated by ptatelet alloimmunization[J]. Klin Padiatr, 2011, 223(3) :173.

二级参考文献20

  • 1[1]Nair S,Ghosh K,Kulkarni B,et al.Glanzmann's thrombasthenia:updated[J].Platelets,2002,13(7):387-393.
  • 2[2]Fullard JF.The role of the platelet glycoprotein Ⅱb/Ⅲa in thrombosis and haemostasis[J].Curr Pharm Des,2004,10(14):1567-1576.
  • 3[3]Toogeh G,Sharifian R,Lak M,et al.Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran[J].Am J Hematol,2004,77(2):198-199.
  • 4[4]George JN,Caen JP,Nurden AT.Glanzmann's thrombasthenia:the spectrum of clinical disease[J].Blood,1990,75(7):1383-1395.
  • 5[5]Boudreaux MK,Lipscomb DL.Clinical,biochemical,and molecular aspects of Glanzmann's thrombasthenia in humans and dogs[J].Vet Pathol,2001,38(3):249-260.
  • 6[6]Siddiqui MA,Scott LJ.Recombinant factor Ⅶa (Eptacog Alfa):a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders [J].Drug,2005,65(8):1161-1177.
  • 7[7]Poon MC,D'Oiron R,Von Depka M,et al.Prophylactic and therapeutic recombinant factor Ⅶa administration to patients with Glanzmann's thrombasthenia:results of an international survey[J].J Thromb Haemost,2004,2(7):1096-1103.
  • 8[8]Flood VH,Johnson FL,Boshkov LK,et al.Sustained engraftment post bone marrow transplant despite antiplatelet antibodies in Glanzmann thrombasthenia[J].Pediatr Blood Cancer,2005,45(7):971-975.
  • 9[9]Fang J,Hodivala-Dilke K,Johnson BD,et al.Therapeutic expression of the platelet-specific integrin,alphaⅡbbeta3,in a murine model for Glanzmann thrombasthenia[J].Blood,2005,106(8):2671-2679.
  • 10[10]Quinn MJ,Byzova TV,Qin J,et al.Integrin alphaⅡbbeta3 and its antagonism [J].Arterioscler Thromb Vasc Biol,2003,23(6):945-952.

共引文献4

中国实验诊断学
2016年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部